Delivery Order SPE2DB25D3017-SPE2DB25FVKDH
Award Date 8/6/25
Potential Completion Date 8/7/25
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,490.36 to AmerisourceBergen Drug Corp for the supply of HAVRIX 1,440 Unit/ML vaccine syringes. This competitively awarded, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Havrix 720 Unit/0.5 mL syringes, a hepatitis A vaccine product. This firm fixed-price delivery order, valued at $1,647.16, represents a competitively awarded, non-set-aside contract with an ultimate completion date of October 16, 2025. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,012.20 to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 ML syringes on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine product, reflecting the ongoing federal medical procurement needs for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of HAVRIX 1,440 unit/mL syringes, a hepatitis A vaccine product. This non-set-aside, competitively awarded contract is structured as a delivery order with firm fixed pricing and a ceiling value of $3,059.79. The contract is anticipated to reach ultimate completion on July 21, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Havrix 720 Unit/0.5 ML syringes, a hepatitis A vaccine product. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,012.20 and is scheduled for completion by August 8, 2025. The contract utilizes no set-aside designation and represents a direct procurement of pharmaceutical products to support federal healthcare requirements. The place of...
- The Defense Logistics Agency awarded a $3,776.30 delivery order to AmerisourceBergen Drug Corp for Havrix 720 Unit/0.5 mL syringes on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract represents a pediatric hepatitis A vaccine delivery through AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,440 units of Havrix (hepatitis A vaccine) in single-dose syringes, valued at $2,286.70 with a completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation. The vaccine will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $4,048.80 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of HAVRIX 720 Unit/0.5 ML syringes. This firm fixed-price contract, with an ultimate completion date of August 22, 2025, represents a pediatric hepatitis A vaccine delivery to support federal medical procurement needs. The award was made through open competition with no set-aside designation, with performance to take place at AmerisourceBergen's facility in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $4,151.00 by the Defense Logistics Agency on September 22, 2025, for the supply of HAVRIX 720 Unit/0.5 mL syringes. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of September 23, 2025. Performance will take place at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Havrix 1,440 unit/mL syringes, a hepatitis A vaccine product. This firm fixed price delivery order, valued at $2,920.87, is classified as a non-set-aside competitive award with an ultimate completion date of August 19, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery...